3 news items
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
SNGX
STSS
7 Jun 24
million by 2028. Recent FDA recalls and tariffs on Chinese syringes have boosted demand for Sharps' products, which are increasingly preferred over glass
Sharps Technology's SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
STSS
31 May 24
in revenue by 2028 within the currently standing facility. Strategic Commercial Prospects: The recent FDA recalls
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
STSS
28 May 24
syringes in November 2023, resulting in multiple recalls and warnings for these products during the first quarter of 2024, and has advised
- Prev
- 1
- Next